Arima Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Profit 2.26%
(FY 2021)
- Ebitda 2.26%
(FY 2021)
- Net Worth -60.84%
(FY 2021)
- Total Assets %
(FY 2021)
About Arima Life Sciences
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Govindan, Gunasekaran Karthick, and Subashika serve as directors at the Company.
- CIN/LLPIN
U24304TN2019PTC130376
- Company No.
130376
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arima Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govindan  | Director | 08-Jul-2019 | Current |
| Gunasekaran Karthick | Director | 08-Jul-2019 | Current |
| Subashika | Director | 22-Jul-2021 | Current |
Financial Performance of Arima Life Sciences.
Arima Life Sciences Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 2.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 60.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arima Life Sciences?
In 2021, Arima Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arima Software Solutions Private LimitedActive 7 years 6 monthsGunasekaran Karthick is a mutual person
- Arima Trade International Private LimitedActive 2 years 8 months
Gunasekaran Karthick is a mutual person
- Arunachala Consultants Private LimitedActive 9 years 11 months
Gunasekaran Karthick is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arima Life Sciences?
Unlock and access historical data on people associated with Arima Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arima Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arima Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
